Zobrazeno 1 - 10 of 57 pro vyhledávání: '"S S, Pierangeli"'
1
Utilization of intravenous immunoglobulin therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review
Autor: S S Pierangeli, E N Harris
Publikováno v: Scandinavian Journal of Rheumatology. 27:97-102
Although experience is still limited, intravenous immunoglobulin therapy for recurrent pregnancy loss in the Antiphospholipid Syndrome (APS) may represent a significant advance. APS was widely recognized only fifteen years ago. Pregnancy loss and thr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92871699bccff61fa3e14c9aefa06019
https://doi.org/10.1080/03009742.1998.11720777
Zobrazit plný text záznamu
2
A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis
Autor: S Krnic-Barrie, C R O'Connor, E N Harris, S S Pierangeli, Stephen W. Looney
Publikováno v: Archives of Internal Medicine. 157:2101-2108
Background: Antiphospholipid syndrome (APS) is a disorder of recurrent venous or arterial thrombosis, pregnancy losses, and thrombocytopenia. Recurrent thrombosis has particularly adverse effects on patient prognosis. The factors that influence recur
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ae38d831723c29286dbfb4e2d9e7a45
https://doi.org/10.1001/archinte.157.18.2101
Zobrazit plný text záznamu
3
Interactions and molecular structure of cardiolipin and β2-glycoprotein 1 (β2-GP1)
Autor: O. P. Lamba, E. N. Harris, Douglas Borchman, S. S. Pierangeli
Publikováno v: Clinical and Experimental Immunology. 102:373-378
SUMMARY β2-GP1 is a serum protein which influences binding of anticardiolipin antibodies to cardiolipin, may influence induction of these antibodies in animals and may play a role in anticardiolipin-mediated thrombosis. Various investigators have pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4a8131dd65b0989416a039acaf6f4f
https://doi.org/10.1111/j.1365-2249.1995.tb03792.x
Zobrazit plný text záznamu
4
Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort
Autor: R, Willis, A M, Seif, G, McGwin, L A, Martinez-Martinez, E B, González, E, Doan, N, Dang, E, Papalardo, J, Liu, L M, Vilá, J D, Reveille, G S, Alarcón, S S, Pierangeli
Publikováno v: Clinical and experimental rheumatology. 32(2)
We sought to determine the effect of statin therapy on the levels of proinflammatory/prothrombotic markers and disease activity scores in patients with SLE in a multi-ethnic, multi-centre cohort (LUMINA).Plasma/serum samples from SLE patients placed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e81adde0fa825746c9c86c98a54f13c2
https://pubmed.ncbi.nlm.nih.gov/24480124
Zobrazit plný text záznamu
5
Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2 glycoprotein 1 or anticardiolipin antibodies alone
Autor: E. N. Harris, S. S. Pierangeli
Publikováno v: Clinical and Experimental Immunology. 93:269-272
SUMMARY Anticardiolipin (aCL) antibodies are autoantibodies present in high concentrations in patients with the antiphospholipid syndrome (APS), a disorder of recurrent thrombosis and pregnancy loss. What induces aCL antibodies is uncertain, but a re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf735917a2139ebaa6703ba02ae4ec4
https://doi.org/10.1111/j.1365-2249.1993.tb07978.x
Zobrazit plný text záznamu
6
[Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases]
Autor: G F, de Larrañaga, N, Harris, S S, Pierangeli, B S, Alonso, T, Schroder, H, Fainboim
Publikováno v: Medicina. 60(6)
Antiphospholipid antibodies (aPL) have been associated with different diseases. They are defined as a large family of immunoglobulins (Ig) of either alloantibodies or autoantibodies. The autoimmune antibodies are associated with venous and/or arteria
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9b82e32113c6695d6af34cfd269750e7
https://pubmed.ncbi.nlm.nih.gov/11436702
Zobrazit plný text záznamu
8
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype
Autor: S S, Pierangeli, R, Espinola, X, Liu, E N, Harris, J E, Salmon
Publikováno v: Arthritis and rheumatism. 44(4)
Patients with the antiphospholipid antibody syndrome (APS) often experience recurrent arterial and venous thrombosis and pregnancy losses. Intravenous immunoglobulin (IVIG) therapy has prevented pregnancy loss in some women with APS and has reversed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::76a198cd617debff4d891ba192f0c8ea
https://pubmed.ncbi.nlm.nih.gov/12730514
Zobrazit plný text záznamu
9
Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models
Autor: S S, Pierangeli, X, Liu, R, Espinola, T, Olee, M, Zhu, N E, Harris, P P, Chen
Publikováno v: Thrombosis and haemostasis. 84(3)
Antiphospholipid antibodies (aPL) have been associated with thrombosis and pregnancy losses in patients diagnosed with antiphospholipid syndrome (APS) and enhance thrombus formation in vivo in mice, but the mechanism of thrombosis by aPL is not compl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f94112204236122867b9c1cf14daa051
https://pubmed.ncbi.nlm.nih.gov/11019960
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje